FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma

BACKGROUND: Despite the scarcity of data based on randomized trials, FOLFIRINOX is widely used in the management of borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC). We investigated the clinical outcomes of neoadjuvant FOLFIRINOX in patients w...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Med Oncol
Main Authors: Yoo, Changhoon, Hwang, Inhwan, Song, Tae Jun, Lee, Sang Soo, Jeong, Jae Ho, Park, Do Hyun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Byun, Jae Ho, Park, Jin-hong, Hwang, Dae Wook, Song, Ki Byung, Lee, Jae Hoon, Lee, Woohyung, Chang, Heung-Moon, Kim, Kyu-pyo, Kim, Song Cheol, Ryoo, Baek-Yeol
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498966/
https://ncbi.nlm.nih.gov/pubmed/32983266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920953294
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker